| 1 |
List of new drugs (r-DNA origin) approved for manufacture and marketing in India during the period Feb 2023 to 01 Aug 2023 |
2023-Aug-08 |
|
426 KB |
| 2 |
List of New drugs (r-DNA origin) approved for import and marketing in India during the period Feb 2023 to 01 Aug 2023 |
2023-Aug-07 |
|
317 KB |
| 3 |
List of new drugs r-DNA origin approved for import and marketing in India for the Year 2020 |
2023-May-03 |
|
231 KB |
| 4 |
List of new drugs of r-DNA origin approved in CT-20 for import and marketing in India during the period Jul 2021 to Aug 2022 |
2023-Mar-15 |
|
652 KB |
| 5 |
List of New drugs (r-DNA origin) approved for import and marketing in India in the month JAN 2023 |
2023-Mar-13 |
|
160 KB |
| 6 |
List of new drugs (r-DNA origin) approved for manufacture and marketing in India in the month JAN 2023 |
2023-Mar-13 |
|
285 KB |
| 7 |
List of New drugs (r-DNA origin) approved for import and marketing in India during the period Sep, 2022 to Dec, 2022 |
2023-Feb-14 |
|
40 KB |
| 8 |
List of new drugs (r-DNA origin) approved for manufacture and marketing in India during the period Oct 2022 to Dec 2022 |
2023-Feb-14 |
|
291 KB |
| 9 |
List of new drugs (r-DNA origin) approved for manufacture and marketing in India during the period Jul, 2021 to Sep, 2022 |
2022-Oct-17 |
|
167 KB |
| 10 |
Form CT-20 for the year 2021 till 02.07.2021 |
2021-Jul-01 |
|
64 KB |
| 11 |
Form CT-22 & 23 for Year 2021 till 02.07.2021 |
2021-Jul-01 |
|
65 KB |
| 12 |
CT permission issued for r-DNA derived drugs for the year 2020 |
2020-Nov-11 |
|
85 KB |
| 13 |
List of new drugs (r-DNA origin) approved for manufacture and marketing in India for the Year 2020 |
2020-Nov-11 |
|
72 KB |
| 14 |
CT permission issued for r-DNA derived drugs for the year 2019 |
2020-Nov-10 |
|
88 KB |
| 15 |
Permissions granted in Form 46/46 A |
2020-Feb-03 |
|
133 KB |
| 16 |
Permissions granted in Form 45/45 A |
2020-Feb-02 |
|
311 KB |
| 17 |
List of rDNA Clinical trials to be Inspected as per the Central Inspection Plan-2019 |
2019-May-17 |
|
85 KB |
| 18 |
Central Inspection Plan Using Risk Based Approach of r-DNA products Manufacturing Units for 2019 QA-INS-012 |
2019-May-16 |
|
2815 KB |
